Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity

Damadoglu, Ebru; KARAKAYA, GÜL; Kalyoncu, Ali Fuat; Özdemir, Ebru; karabiber, esra

doi:10.21911/aai.019

Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity

Ebru ÖZDEMİR, (Hacettepe Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Allerji ve Klinik İmmünoloji Bölümü, Ankara, Türkiye)

Esra KARABİBER, (Hacettepe Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Allerji ve Klinik İmmünoloji Bölümü, Ankara, Türkiye)

Ebru ÇELEBİOĞLU, (Hacettepe Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Allerji ve Klinik İmmünoloji Bölümü, Ankara, Türkiye)

Gül KARAKAYA, (Hacettepe Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Allerji ve Klinik İmmünoloji Bölümü, Ankara, Türkiye)

Ali Fuat KALYONCU (Hacettepe Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Allerji ve Klinik İmmünoloji Bölümü, Ankara, Türkiye)

Astım Allerji İmmünoloji

0 0

Yıl: 2022 Cilt: 20 Sayı: 3 Sayfa Aralığı: 172 - 178 Metin Dili: İngilizce DOI: 10.21911/aai.019 İndeks Tarihi: 03-05-2023

Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity

Öz:

Objective: Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) is among the most common drug hypersensitivities. NSAID hypersensitivity (NH) may affect 1-2% of the general population and it is an important public health problem that affects medical prescriptions, practices, and interventions. It also has an influence on the quality of the patients’ daily lives. The primary aim was to understand to what extent a patient feels or perceives the symptoms and complaints during an NH reaction and to grade it with the visual analogue scale (VAS). The secondary aim was to investigate whether there was a difference between the NSAID groups causing the reactions in terms of reaction type and severity. Materials and Methods: A total of 174 patients with a diagnosis of NH were evaluated in our outpatient allergy clinic. NH reactions were classified as asthma/rhinitis, urticaria/angioedema (u/ae), mixed reaction (asthma/rhinitis and u/ae together), anaphylaxis, and delayed hypersensitivity reaction. Patients were asked to evaluate the severity of each drug reaction by using VAS. Results: Among 174 patients (115 females, mean age 39.12±12.34 years) the propionic acid group was the leading cause of hypersensitivity reactions. Only 3% of the reactions were reported to be mild and all of those mild reactions were u/ae whereas 92% of the anaphylactic reactions were severe. Most of the reactions were of the u/ae type. The acetic acid group was the leading cause of anaphylactic reactions. Conclusion: NSAIDs cause reactions of various types with various levels of severity. These reactions are perceived by patients at different severity levels. VAS can provide a simple and quick assessment to evaluate NH reaction severity quantitatively.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume to substitutes. Lancet 1977;1:466-9.
2. The World Health Report 2008. Primary health care-now more than ever. Geneva: World Health Organization, 2008.
3. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: Conceptual issues. Value Health 2007;10 (Suppl. 2):66-75.
4. Baiardini I, Braido F, Fassio O, Calia R, Giorgio WC, Romano A; DrHy-Q PROs Research Italian Group. Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Ann Allergy Asthma Immunol 2011;106(4):330- 5.
5. Shafshak TS, Elnemr R. The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain. J Clin Rheumatol 2021;1;27(7):282-5.
6. Huang Z, Kohler IV, Kämpfen F. A Single-Item Visual Analogue Scale (VAS) Measure for Assessing Depression Among College Students. Community Ment Health J 2020;56(2):355-67.
7. Martin Nguyen A, Bacci ED, Vernon M, Birring SS, Rosa C, Muccino D, et al. Validation of a visual analog scale for assessing cough severity in patients with chronic cough. Ther Adv Respir Dis 2021;15:17534666211049743.
8. Elera-Fitzcarrald C, Vega K, Gamboa-Cárdenas RV, Zúñiga K, evallos F, Reátegui-Sokolova C, et al. Reliability of Visual Analog Scale and Numeric Rating Scale for the Assessment of Disease Activity in Systemic Lupus Erythematosus. J Clin Rheumatol 2020;26(7S Suppl 2):170-3.
9. Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Postcovid-19 Asthenic Syndrome. Neurosci Behav Physiol 2022;18:1-5.
10. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: A reanalysis of two clinical trials of postoperative pain. J Pain 2003;4:407-14.
11. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al. Hypersensitivity to nonsteroidal antiinflammatory drugs (NSAIDs)—classification, diagnosis and management: Review of the EAACI/ENDA(#) and GA2LEN/HANN A. Allergy 2011;66:818-29.
12. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal antiinflammatory drugs. Allergy 2013;68:1219-32.
13. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Koyama H, et al. Longitudinal changes in patient vs. physician-based outcome measures did not significantly correlate in asthma. J Clin Epidemiol 2005;58(5):532-9.
14. Jenkins CR, Thompson PJ, Gibson PG, Wood-Baker R. Distinguishing asthma and chronic obstructive pulmonary disease: Why, why not and how? Med J Aust 2005;4;183(1 Suppl):35-7.
15. Haughney J, Cotton P, Rosen JP, Morrison K, Price D. The use of a modification of the Patient Enablement Instrument in asthma. Prim Care Respir J 2007;16:89-92.
16. Fox P, Porter PG, Lob SH, Boer JH, Rocha DA, Adelson JW. Improving asthma-related health outcomes among low-income, multiethnic, school-aged children: Results of a demonstration project that combined continuous quality improvement and community health worker strategies. Pediatrics 2007;120:902- 11.
17. Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ. AKL1, a botanical mixture for the treatment of asthma: A randomised, double-blind, placebo-controlled, cross-over study. BMC Pulm Med 2007;7:4.
18. Karakaya G, Celebioglu E, Kalyoncu AF. Non-steroidal antiinflammatory drug hypersensitivity in adults and the factors associated with asthma. Respir Med 2013;107(7):967-74.
19. Nissen CV, Bindslev-Jensen C, Mortz CG. Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): Classification of a Danish patient cohort according to EAACI/ENDA guidelines. Clin Transl Allergy 2015;5:10.
20. Atchison JW, Herndon CM, Rusie E. NSAIDs for musculoskeletal pain management: Current perspectives and novel strategies to improve safety. J Manag Care Pharm 2013;19(9 Suppl A):S3-S19.
21. García Rodríguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol 2008;52(20):1628-36.
22. Grosser T, Fries S, Fitzgerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: Therapeutic challenges and opportunities. J Clin Invest 2006;116(1):4-15.
23. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345(6):433-42.
24. Patrignani P, Tacconelli S, Bruno A, Sostres C, Lanas A. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert Rev Clin Pharmacol 2011;4(5):605-21.
25. Botting RM. Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? Clin Infect Dis 2000;31(Suppl 5):S202-10.
26. van der Klauw MM, Wilson JH, Stricker BH. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974- 1994) and review of the literature. Clin Exp Allergy 1996;26:1355- 63.
27. Chaudhry T, Hissaria P, Wiese M, Heddle R, Kette F, Smith WB. Oral drug challenges in non-steroidal anti-inflammatory druginduced urticaria, angioedema and anaphylaxis. Intern Med J 2012;42(6):665-71.
28. Demir S, Olgac M, Unal D, Gelincik A, Colakoglu B, Buyukozturk S. Evaluation of hypersensitivity reactions to nonsteroidal antiinflammatory drugs according to the latest classification. Allergy 2015;70(11):1461-67.
29. Kalyoncu AF, Karakaya G, Sahin AA, Bariş YI. Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy 1999;54(5):428-35.

APA	Özdemir E, karabiber e, Damadoglu E, KARAKAYA G, Kalyoncu A (2022). Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. , 172 - 178. 10.21911/aai.019
Chicago	Özdemir Ebru,karabiber esra,Damadoglu Ebru,KARAKAYA GÜL,Kalyoncu Ali Fuat Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. (2022): 172 - 178. 10.21911/aai.019
MLA	Özdemir Ebru,karabiber esra,Damadoglu Ebru,KARAKAYA GÜL,Kalyoncu Ali Fuat Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. , 2022, ss.172 - 178. 10.21911/aai.019
AMA	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. . 2022; 172 - 178. 10.21911/aai.019
Vancouver	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. . 2022; 172 - 178. 10.21911/aai.019
IEEE	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A "Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity." , ss.172 - 178, 2022. 10.21911/aai.019
ISNAD	Özdemir, Ebru vd. "Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity". (2022), 172-178. https://doi.org/10.21911/aai.019

APA	Özdemir E, karabiber e, Damadoglu E, KARAKAYA G, Kalyoncu A (2022). Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. Astım Allerji İmmünoloji, 20(3), 172 - 178. 10.21911/aai.019
Chicago	Özdemir Ebru,karabiber esra,Damadoglu Ebru,KARAKAYA GÜL,Kalyoncu Ali Fuat Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. Astım Allerji İmmünoloji 20, no.3 (2022): 172 - 178. 10.21911/aai.019
MLA	Özdemir Ebru,karabiber esra,Damadoglu Ebru,KARAKAYA GÜL,Kalyoncu Ali Fuat Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. Astım Allerji İmmünoloji, vol.20, no.3, 2022, ss.172 - 178. 10.21911/aai.019
AMA	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. Astım Allerji İmmünoloji. 2022; 20(3): 172 - 178. 10.21911/aai.019
Vancouver	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity. Astım Allerji İmmünoloji. 2022; 20(3): 172 - 178. 10.21911/aai.019
IEEE	Özdemir E,karabiber e,Damadoglu E,KARAKAYA G,Kalyoncu A "Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity." Astım Allerji İmmünoloji, 20, ss.172 - 178, 2022. 10.21911/aai.019
ISNAD	Özdemir, Ebru vd. "Visual Analogue Scale is A Simple and Quick Tool to Evaluate Drug Reaction Severity". Astım Allerji İmmünoloji 20/3 (2022), 172-178. https://doi.org/10.21911/aai.019